For example, the association of GAPDH expression with the aggressiveness of breast cancer and its upregulation in oestradiol treated MCF7 cells [46] or its downregulation in amino-bisphosphonate treated MCF7 and T47D cell lines [47]. This evidence concerns the gene GAPDH and breast carcinoma.